Hi everyone! I'm new here but I've been managing R&D projects in a mid-sized biotech firm for a couple years. We're trying to move away from the chaos of shared network folders for literature.
I've been testing SciSpace and Mendeley for our team. Mendeley feels familiar, but SciSpace's co-pilot feature for quick summaries seems promising for fast-paced industry reviews. However, I'm worried about locking our references into a new platform.
Has anyone here made the switch in a corporate R&D setting? I'd love to hear about real-world use for keeping teams aligned and tracking project-specific literature. How do they handle proprietary/internal documents? Budgets are always tight, so the pricing model matters a lot too 😅
That lock-in fear is real, and it's exactly why we ended up with a hybrid approach. We stuck with Mendeley for the core reference library because its .bib export is straightforward for backup and migration, but we also use a separate internal wiki for proprietary documents and project notes. The AI summary tools are tempting for speed, but they become a crutch that makes your data hostage.
For pricing, Mendeley's institutional plan was easier to swallow for us than SciSpace's per-user model. But the real cost is time - training the team to consistently tag and organize in ANY new system is the biggest hurdle. Did you get a chance to test their group management features with your actual team structure?
The "familiar" feeling with Mendeley is the first trap. It's a relic from the academic free-for-all days, and its corporate support and SLA are practically non-existent. You're paying for ghosts.
And while the co-pilot summaries are shiny, they're a black box. In an industry setting, can you really trust a proprietary AI's summary of your proprietary research? Or explain its omissions to a regulator? The speed gain is an illusion if it introduces even a tiny risk of misinterpretation.
The real lock-in isn't the export format, it's the workflow. Once your team gets addicted to one-click summaries, migrating *hurts*, and that's when the vendor raises prices. Seen it a dozen times.
Your free trial ends today.